Skip to main content

Table 1 Patient population characteristics

From: Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer

  n %
Patients 60 100
 Male 36 60
 Female 24 40
Age at diagnosis (years)
 Median 62  
 Range 43–81  
Age at testing (years)
 Median 64  
 Range 43–81  
Personal history
 Available 49 81.7
 Other cancera 10 20.4
  Breast 5b  
  Ovarian 0  
  Other 6  
 No other cancer 39 79.6
 Not available 11 18.3
Family historyc
 Available 32 53.3
 Cancera 23 71.9
  Pancreatic 4  
  Breast 12  
  Ovarian 1  
  Other 16  
 No cancer 9 28.1
 Not available 28 46.7
  1. a some patients have history of ≥2 cancers; b 5 + 1 in situ; c first-grade and second-grade relatives